vs
Side-by-side financial comparison of BlackSky Technology Inc. (BKSY) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $35.2M, roughly 1.4× BlackSky Technology Inc.). BlackSky Technology Inc. runs the higher net margin — -2.5% vs -4.8%, a 2.3% gap on every dollar of revenue. On growth, BlackSky Technology Inc. posted the faster year-over-year revenue change (15.9% vs -47.3%). Over the past eight quarters, BlackSky Technology Inc.'s revenue compounded faster (20.5% CAGR vs -20.2%).
BlackSky Technology Inc. is a leading geospatial intelligence provider operating a constellation of high-revisit small Earth observation satellites. It delivers real-time satellite imagery, advanced data analytics, and dynamic monitoring solutions to government, defense, critical infrastructure, and commercial clients globally to support data-driven operational decision-making.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
BKSY vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $35.2M | $47.7M |
| Net Profit | $-868.0K | $-2.3M |
| Gross Margin | — | — |
| Operating Margin | -11.8% | 14.3% |
| Net Margin | -2.5% | -4.8% |
| Revenue YoY | 15.9% | -47.3% |
| Net Profit YoY | 95.5% | -200.9% |
| EPS (diluted) | $0.04 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $35.2M | $47.7M | ||
| Q3 25 | $19.6M | $122.1M | ||
| Q2 25 | $22.2M | $85.2M | ||
| Q1 25 | $29.5M | $41.1M | ||
| Q4 24 | $30.4M | $90.5M | ||
| Q3 24 | $22.5M | $91.6M | ||
| Q2 24 | $24.9M | $94.4M | ||
| Q1 24 | $24.2M | $74.9M |
| Q4 25 | $-868.0K | $-2.3M | ||
| Q3 25 | $-15.3M | $40.1M | ||
| Q2 25 | $-41.2M | $23.6M | ||
| Q1 25 | $-12.8M | $-37.4M | ||
| Q4 24 | $-19.4M | $2.3M | ||
| Q3 24 | $-12.6M | $3.6M | ||
| Q2 24 | $-9.4M | $-860.0K | ||
| Q1 24 | $-15.8M | $-4.2M |
| Q4 25 | -11.8% | 14.3% | ||
| Q3 25 | -85.8% | 61.8% | ||
| Q2 25 | -62.8% | 53.2% | ||
| Q1 25 | -40.5% | -70.7% | ||
| Q4 24 | -20.0% | 34.8% | ||
| Q3 24 | -58.7% | 28.0% | ||
| Q2 24 | -47.0% | 26.5% | ||
| Q1 24 | -54.7% | 14.7% |
| Q4 25 | -2.5% | -4.8% | ||
| Q3 25 | -78.2% | 32.8% | ||
| Q2 25 | -185.8% | 27.7% | ||
| Q1 25 | -43.4% | -90.9% | ||
| Q4 24 | -63.9% | 2.5% | ||
| Q3 24 | -55.8% | 4.0% | ||
| Q2 24 | -37.7% | -0.9% | ||
| Q1 24 | -65.2% | -5.6% |
| Q4 25 | $0.04 | $0.01 | ||
| Q3 25 | $-0.44 | $0.23 | ||
| Q2 25 | $-1.27 | $0.14 | ||
| Q1 25 | $-0.42 | $-0.23 | ||
| Q4 24 | $-0.61 | $0.03 | ||
| Q3 24 | $-0.66 | $0.02 | ||
| Q2 24 | $-0.52 | $-0.01 | ||
| Q1 24 | $-0.88 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $124.5M | $215.5M |
| Total DebtLower is stronger | $201.1M | — |
| Stockholders' EquityBook value | $94.9M | $-261.8M |
| Total Assets | $386.2M | $396.9M |
| Debt / EquityLower = less leverage | 2.12× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $124.5M | $215.5M | ||
| Q3 25 | $146.5M | $140.4M | ||
| Q2 25 | $93.8M | $92.9M | ||
| Q1 25 | $75.8M | $108.5M | ||
| Q4 24 | $52.5M | $88.6M | ||
| Q3 24 | $63.2M | $88.2M | ||
| Q2 24 | $41.2M | $105.5M | ||
| Q1 24 | $35.4M | $121.5M |
| Q4 25 | $201.1M | — | ||
| Q3 25 | $195.1M | $199.5M | ||
| Q2 25 | $122.5M | $199.3M | ||
| Q1 25 | $115.3M | $199.2M | ||
| Q4 24 | $107.7M | $199.0M | ||
| Q3 24 | $98.8M | $198.8M | ||
| Q2 24 | $108.6M | $198.6M | ||
| Q1 24 | $85.0M | $398.3M |
| Q4 25 | $94.9M | $-261.8M | ||
| Q3 25 | $91.1M | $-264.2M | ||
| Q2 25 | $86.6M | $-308.2M | ||
| Q1 25 | $88.8M | $-334.1M | ||
| Q4 24 | $94.0M | $-301.3M | ||
| Q3 24 | $110.3M | $-311.3M | ||
| Q2 24 | $76.5M | $-321.7M | ||
| Q1 24 | $81.7M | $-330.5M |
| Q4 25 | $386.2M | $396.9M | ||
| Q3 25 | $380.9M | $396.1M | ||
| Q2 25 | $310.8M | $342.9M | ||
| Q1 25 | $284.9M | $327.2M | ||
| Q4 24 | $254.1M | $350.9M | ||
| Q3 24 | $245.5M | $389.5M | ||
| Q2 24 | $224.3M | $395.6M | ||
| Q1 24 | $210.1M | $438.8M |
| Q4 25 | 2.12× | — | ||
| Q3 25 | 2.14× | — | ||
| Q2 25 | 1.41× | — | ||
| Q1 25 | 1.30× | — | ||
| Q4 24 | 1.15× | — | ||
| Q3 24 | 0.90× | — | ||
| Q2 24 | 1.42× | — | ||
| Q1 24 | 1.04× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-9.3M | $74.6M |
| Free Cash FlowOCF − Capex | — | $74.6M |
| FCF MarginFCF / Revenue | — | 156.3% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-9.3M | $74.6M | ||
| Q3 25 | $-39.0M | $47.6M | ||
| Q2 25 | $-7.3M | $-15.1M | ||
| Q1 25 | $27.2M | $20.0M | ||
| Q4 24 | $-1.8M | $15.2M | ||
| Q3 24 | $1.0M | $9.9M | ||
| Q2 24 | $-1.8M | $33.5M | ||
| Q1 24 | $-3.8M | $45.0M |
| Q4 25 | — | $74.6M | ||
| Q3 25 | — | $47.6M | ||
| Q2 25 | — | $-15.1M | ||
| Q1 25 | — | $19.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $9.9M | ||
| Q2 24 | — | $33.4M | ||
| Q1 24 | — | $44.9M |
| Q4 25 | — | 156.3% | ||
| Q3 25 | — | 39.0% | ||
| Q2 25 | — | -17.7% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 10.8% | ||
| Q2 24 | — | 35.4% | ||
| Q1 24 | — | 60.0% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | -0.64× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | — | 2.71× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
